In three different HCC subtypes proposed by Chaisaingmongkol et al., EHMT2 expression (in mRNA level) still exhibited considerable discrimination (with HR > 2.1) in the overall survival of patients with HCC. This evidence concerns the gene EHMT2 and hepatocellular carcinoma.